427 BEATcc (ENGOT-CX10/GEICO 68-C/JGOG1084/GOG-3030), a randomised phase 3 trial of first-line atezolizumab with bevacizumab and platinum-based chemotherapy for metastatic (stage IVB), persistent or recurrent cervical cancerAna Oaknin,Laurence Gladieff, Jerónimo Martínez,Guillermo Villacampa,Munetaka Takekuma,Ugo De Giorgi,Kristina Lindemann,Linn Woelber,Nicoletta Colombo,Linda R Duska,Alexandra Leary, Ana Godoy-Ortiz,Shin Nishio,Antoine Angelergues,María Jesús Rubio,Lorena Fariñas-Madrid,Satoshi Yamaguchi,Domenica Lorusso, Véronique D’hondt,Leslie M RandallOral Sessions（2024）引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
